Evidence map›Paper›PMID 38280151›Full record

ArticleBiochemical genetics2024

NPC1L1 rs217434 A > G as a Novel Single Nucleotide Polymorphism Related to Dyslipidemia in a Korean Population.

Dahyun Cho, Ximei Huang, Youngmin Han, Minjoo Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dahyun Cho *Department of Food and Nutrition, College of Life Science and Nano Technology, Hannam University, Daejeon, 34054, Republic of Korea.
Ximei Huang *Department of Food and Nutrition, College of Life Science and Nano Technology, Hannam University, Daejeon, 34054, Republic of Korea.
Youngmin HanInstitute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, 03722, Republic of Korea.
Minjoo KimDepartment of Food and Nutrition, College of Life Science and Nano Technology, Hannam University, Daejeon, 34054, Republic of Korea. minjookim@hnu.kr.

Funding

National Research Foundation of Korea NRF-2019R1I1A2A01061731
6 · The paper itself

Abstract

A relationship between cholesterol levels and Niemann-Pick C1-Like 1 (NPC1L1) polymorphisms in diverse populations was found in previous studies. However, relevant research on this association in the Korean population is relatively scarce. Therefore, the current study sought to examine the correlation between the NPC1L1 rs217434 A > G polymorphism and clinical as well as biochemical variables pertaining to dyslipidemia in the Korean population. This cross-sectional single-center study included 1404 Korean subjects aged 20-86 years, grouped based on dyslipidemia presence (normal and dyslipidemia) and genotype (AA or AG). After adjusting for sex and age, it was discovered that the dyslipidemia group's BMI, diastolic blood pressure, glucose-related indicators, lipid profile, high-sensitivity C-reactive protein (hs-CRP), and parameters of oxidative stress were considerably different from the normal group's values. When grouped according to genotype, individuals in the AG group exhibited greater total cholesterol, low-density lipoprotein cholesterol, hs-CRP, and 8-epi-prostaglandin F

Indexed as

DyslipidemiasMembrane ProteinsMembrane Transport ProteinsPolymorphism, Single NucleotideAdultAgedAged, 80 and overCross-Sectional StudiesEast Asian PeopleFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedRepublic of KoreaMembrane ProteinsMembrane Transport ProteinsNPC1L1 protein, humanCholesterolDyslipidemiaNPC1L1Polymorphism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.